FDA Clearance Tracker · P990018-S008
Menicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear; ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overni
Last checked: Nov 20, 2026Latest source record: Aug 2, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Aug 2, 2022
Approved
Time to decision
176 days
Received Feb 7, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990018-S008
- Device name
- Menicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear; ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overni
- Applicant
- Menicon Co, Ltd.
- Applicant location
- Nagoya
- Received
- Feb 7, 2022
- Decided
- Aug 2, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P990018
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.5916
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for an expanded range of myopia treatment of up to 6.00 diopters (manifest spherical equivalent).
Source documents
Other decisions for Menicon Co, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262495 · Decided Sep 17, 2026 · 59 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.